Drug Week articles from September 2004

Drug Week archives from September 2004

Orphan drug designation granted from U.S. FDA for Efaproxyn.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics (ALTH) announced that the U.S. Food and Drug Administration (FDA) awarded orphan drug status to the company's lead clinical candidate, Efaproxyn (efaproxiral) for use as an adjunct to...

Study: Therapy cuts diabetic ulcer rate by 79%.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Anodyne Therapy, LLC, announced the publication of a fifth peer-reviewed clinical study demonstrating restoration of sensation in the feet of patients with peripheral neuropathy. The purpose of the...

Combination of erection pill, testosterone gel may help when pill alone fails.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- For men with erectile dysfunction and low testosterone who do not respond to Viagra (sildenafil) alone, the supplemental use of AndroGel (testosterone gel) improves erectile function and overall sexual...

Study: Requip reduces periodic leg movements in patients with RLS.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- New data published in August 2004 shows patients with primary restless legs syndrome (RLS) and with periodic leg movements during sleep (PLMS) have fewer awakenings resulting from involuntary kicks when...

sNDA submitted for Merrem I.V. for complicated skin infections.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- AstraZeneca Pharmaceuticals LP has announced that it has submitted a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration (FDA) seeking approval for a new indication for...

Malnutrition increases risk of acquired immunodeficiency syndrome.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Malnutrition increases risk of acquired immunodeficiency syndrome. According to recent research from the United States, "Infectious diseases are the major causes of death and morbidity in...

Challenges in the search for HIV vaccine outlined.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Researchers outline challenges in the search for an HIV vaccine in a recent issue of the European Journal of Epidemiology. "Considerable progress has been made over the past several years in the...

DNA prime-MVA boost HIV vaccine tailored for eastern and central Africa.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Researchers have developed a DNA prime-MVA boost HIV vaccine tailored for eastern and central Africa. According to a study from England, "For the development of human immunodeficiency virus type 1...

T cell-based control of SIV replication in AIDS vaccine trial reported.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Researchers report cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. "Recently, encouraging AIDS vaccine trials in macaques have...

AML-associated mutant inhibits differentiation of myeloid/erythroid stem cells.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- An acute myeloid leukemia-associated mutant inhibits differentiation of myeloid/erythroid stem cells. "The CCAAT/enhancer binding protein alpha (C/EBPalpha) is an essential transcription factor for...

Antibody against VEGF receptor arrests human leukemia cell proliferation.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Antibody against VEGF receptor arrests human leukemia cell proliferation. "Vascular endothelial growth factor (VEGF) and its receptors (VEGFR) have been implicated in promoting solid tumor growth...

Buprenorphine for treatment of opiate dependence reviewed.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- A researcher reviews buprenorphine for the treatment of opiate dependence in a recent issue of the Journal of Psychoactive Drugs. According to a study from the United States, "Buprenorphine's...

FDA approves Campral Delayed-Release Tablets for treating alcohol dependence.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Forest Laboratories, Inc., (FRX) and Merck, KGaA, (Merck) of Darmstadt, Germany, announced the United States Food and Drug Administration (FDA) has approved Campral (acamprosate calcium) Delayed-Release...

Agency highlights risk of adverse drug reactions arising from the use of SonoVue.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Because of a risk of serious adverse drug reactions, the European Medicines Evaluation Agency, EMEA, has decided to limit the use of SonoVue by means of a so-called urgent procedure. Thus, the use...

Clopidogrel-associated autoimmune thrombocytopenic purpura reported.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- A case of clopidogrel-associated autoimmune thrombocytopenic purpura has been reported. Physcians in the United States described their experience treating "a 51-year-old male who underwent coronary...

Brief intervention can help alcohol abusers.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- According to national surveys, nearly a third of Americans consume more than the U.S. Food and Drug Administration (FDA)-recommended two drinks a day. In the last 2 decades, treatment professionals...

President Bush signs bill that will benefit millions with food allergies.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- The Food Allergy Initiative celebrates a major victory in its public policy campaign as President George W. Bush signed the Food Allergen Labeling and Consumer Protection Act (S. 741) into law. The...

CD28 is required in the effector phase of allergic airway inflammation.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- A new study reveals a requirement for CD28 in the effector phase of allergic airway inflammation. According to a study from the United States, "Central to the pathogenesis of allergic airway...

Sinusitis, rhinosinusitis reclassified by task force as inflammatory diseases.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- A group of leading allergists and otolaryngologists recently published a paper reclassifying sinusitis and rhinosinusitis as inflammatory diseases triggered by mold and bacteria in the nose and sinuses....

Children with serious insect-sting allergies should get shots.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Children who have severe allergic reactions when stung by bees, wasps and other insects should receive venom immunotherapy, or allergy shots, to reduce the chance of future life-threatening reactions if...

Quaternary ammonium compounds exhibit adjuvant effect in murine model.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Quaternary ammonium compounds exhibit an adjuvant effect in a murine model. "It has been suggested that occupational exposure to quaternary ammonium compounds (QACs) may promote the development of...

Tolerance in T cells accompanied by effector function in lymphoid organs.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Oral tolerance in T cells is accompanied by induction of effector function in lymphoid organs after systemic immunization. "The physiological ramifications of oral tolerance remain poorly...

Amyloid accumulation in Alzheimer disease is response to chronic stress.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Amyloid accumulation in Alzheimer disease is a response to chronic stress. "Amyloid deposition within cerebral vessels, or cerebral amyloid angiopathy (CAA), is common in advanced age and even more...

Drug discovery company receives award from Institute on Aging.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- ProteoTech (Proteoglycan Technologies) Inc. announced that it has received a Phase I small business research (SBIR) award from the U.S. National Institute on Aging. The $520,840 award to ProteoTech...

Researchers find protein that may control progression of Alzheimer disease.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Researchers in the Department of Neurosciences at The Cleveland Clinic Lerner Research Institute have found that Nogo, a protein known for its ability to regulate nerve regeneration, may control the...

Transgenic animal models of Alzheimer disease reviewed.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Researchers review transgenic animal models of Alzheimer disease and related disorders in a recent issue of Molecular Psychiatry. "Alzheimer disease (AD) is a devastating neurodegenerative disease...

Testing of Alzheimer vaccines needed in non-murine models.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Alzheimer vaccines must be thoroughly tested in non-murine animal models before trials begin in humans. According to a study from Australia and the United States, "Recent clinical and...

CHIP promotes proteasomal degradation of familial ALS-linked mutant.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Researchers from Japan report that carboxyl terminus of the Hsc70-interacting protein (CHIP) promotes proteasomal degradation of familial amyotrophic lateral sclerosis (ALS) -linked mutant SOD1 by...

New biomarker study to identify unique metabolic signatures for ALS.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Metabolon, Inc., announced its collaboration with Massachusetts General Hospital on a new biomarker study to identify unique metabolic signatures for amyotrophic lateral sclerosis (ALS) that will lead...

Aranesp receives positive regulatory opinion for extended dosing in E.U.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Amgen Inc. (AMGN) announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to expand the marketing authorization for Aranesp (darbepoetin alfa) in...

Trial of Ranexa initiated for certain patients with chronic angina.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- CV Therapeutics, Inc., (CVTX) announced that it has initiated an approval-enabling study of Ranexa, which, if successful, could support approval of Ranexa for the treatment of chronic angina in a...

BNO69 angiogenesis gene discovery published in scientific journal.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Bionomics Limited (BMICY) announced that research conducted by Bionomics and its collaborators at the Hanson Centre of the Institute of Medical and Veterinary Science (IMVS) in Adelaide, Australia,...

Inflammatory cytokines referee angiogenic control during inflammation.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Inflammatory cytokines referee angiogenic control during inflammation. "Vigorous inflammatory responses are associated with tissue damage, particularly when toxic levels of inflammatory cytokines...

Intracoronary transfer of adenylyl cyclase increases left ventricle function.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Intracoronary transfer of adenylyl cyclase increases left ventricle function. According to scientists in the United States, "we performed indirect intracoronary delivery of adenovirus vectors in...

Recall of Taxus coronary stent system expanded.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Angiotech Pharmaceuticals, Inc.'s, (ANPI, ANP) corporate partner, Boston Scientific, provided an update on the Taxus Express(2TM) Paclitaxel-Eluting Coronary Stent System. On July 2 and 16, Boston...

Glucose homeostasis and insulin signaling characterized in mice strains.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Scientists have characterized glucose homeostasis and tissue transcript content of insulin signaling intermediates in four inbred strains of mice. "Transgenic mice phenotypes generally depend on the...

Prophylactic use of antibiotic bone cement is an emerging standard.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Prophylactic use of antibiotic bone cement is an emerging standard--in opposition. According to a report from the United States, "Antibiotic-loaded bone cement (ABLC) is an effective delivery...

Construction of new formulation facilities for micafungin complete.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Fujisawa Pharmaceutical Co., Ltd., announced the company completed construction of new formulation facilities for micafungin. Micafungin, a candin antifungal agent discovered and developed by...

RNAIII-inhibiting peptide suppresses drug-resistant staphylococcal infections.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- RNAIII-inhibiting peptide suppresses drug-resistant staphylococcal infections. According to a study from the United States, "Staphylococcus aureus and S. epidermidis are major causes of infection...

Heme oxygenase attenuates the effects of pyrrolidinedithiocarbamate.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Heme oxygenase attenuates the effects of pyrrolidinedithiocarbamate. "Pyrrolidinedithiocarbamate (PDTC) is a metal-chelating compound that exerts both pro-oxidant and antioxidant effects and is...

Induction of metallothionein requires transcription factor and zinc.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- The induction of metallothionein I by phenolic antioxidants requires metal-activated transcription factor 1 (MTF-1) and zinc. "Phenolic antioxidants, such as tBHQ...

VEGF receptor-3 protects endothelial cells from oxidative stress.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- VEGF receptor-3 protects endothelial cells from oxidative stress. "Reactive oxygen species (ROS) mediate cell damage and have been implicated in the pathogenesis of diseases that involve endothelial...

Efavirenz plasma levels reproducibly predictive of primary treatment failure.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Efavirenz plasma levels are reproducibly predictive of primary treatment failure in HIV-infected patients. According to recent research from Sweden, "Efavirenz is a drug subject to extensive...

Novel benzodithiazines are nontoxic and have anti-HIV-1 integrase activity.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Novel benzodithiazines are nontoxic and have anti-HIV-1 integrase activity. "HIV-1 integrase (IN) is an essential enzyme for effective viral replication and is an attractive target for selective...

Pancreatitis associated with didanosine plus tenofovirin in HIV infection.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Pancreatitis is associated with coadministration of didanosine and tenofovirin in HIV infection. "The rise in didanosine concentrations in plasma when given with tenofovir raises concern for a high...

Ritonavir decreases nonrenal clearance of digoxin.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Ritonavir decreases the nonrenal clearance of digoxin. "Our objective was to examine the influence of ritonavir on P-glycoprotein (P-gp) activity in humans by characterizing the effect of ritonavir...

Sustained benefit of HAART lost when prisoners return to community.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- The sustained benefit of highly active antiretroviral therapy is lost when HIV-1-infected prisoners return to the community. "Responses to highly active antiretroviral therapy (HAART) in...

Antisense RNA staunches glioma angiogenesis and growth.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Antisense RNA staunches glioma angiogenesis and growth. According to recent research from Japan, "malignant gliomas, most of which show an elevated level of vascular endothelial cell growth factor...

Levan polysaccharides have strong antitumor activity.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Levan polysaccharides have strong antitumor activity. According to recent research from South Korea, "Levans were isolated from the cultures of Gluconoacetobacter xylinus (G-levan; M-w=40,000),...

Biofeedback helps asthmatics reduce steroid use.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Biofeedback, the conscious control of body functions through the use of electronic monitoring devices, may help asthmatic patients use inhaled steroids less. Researchers from Robert Wood Johnson...

Atherosclerosis progresses less with aggressive lipid lowering.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- The ability to detect atheromatous disease, particularly in the early stages of development, must be accompanied by effective systemic pharmacologic therapies, researchers say. "Technologic...

Prostaglandin E[subscript]2 receptors up-regulated in peritoneal macrophages.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Prostaglandin E[subscript]2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production. "Prostaglandin...

U.S. NIH awards nearly $1.5 million for study of human bone precursor cells.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Velcura Therapeutics, Inc. was awarded $1,452,000 to study the mechanisms by which primitive cells develop into mature bone-forming cells. Velcura, as part of its work developing therapies for bone...

tetR real-time PCR detects and quantifies tetracycline-resistant bacteria.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- A tetR real-time PCR assay detects and quantifies tetracycline-resistant bacteria. According to recent research published in the Journal of Biochemical and Biophysical Methods, "Bacteria of implant...

Ion-sensitive nanoparticles escort gene therapy.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Ion-sensitive nanoparticles escort gene therapy. "The organic-inorganic hybrid nanoparticles entrapping oligodeoxynucleotide (ODN) or short interfering RNA (siRNA) were prepared through the...

Beta-glucoside metabolism genes may be involved in biofilm formation.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Beta-glucoside metabolism systems may be involved in the adhesion, biofilm formation, and in vivo gene expression of Streptococcus gordonii. According to scientists writing in the Journal of...

Systolic blood pressure can be influenced with population effects.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- It is important to develop population-wide strategies to reduce individual risk of hypertension. "Individuals from the same population share a number of contextual circumstances that may condition...

Stem cell gene therapy produces regenerative bone protein in healing mice.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Stem cell gene therapy produces regenerative bone protein in healing mice. "Muscle-based gene therapy and tissue engineering hold great promise for improving bone healing. However, the relative...

Novel method developed to quantify botulinum neurotoxin antibodies.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Scientists have applied an in vitro technique to achieve the detection and quantification of botulinum neurotoxin antibodies. According to a study from England, "Detection of Clostridium botulinum...

Midkine promoter-based gene therapy decimates malignant glioma.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Midkine promoter-based gene therapy decimates malignant glioma. "Little is known concerning promoters or gene therapy specific for malignant glioma. To explore the potential use of midkine promoter...

HER-2 amplification can be acquired with breast cancer progression.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Contrary to conventional wisdom, HER-2 gene amplification can be acquired during breast cancer progression. "Amplification and overexpression of the HER-2 oncogene in breast cancer is felt to be...

Bcl-2 antisense oligodeoxynucleotide chemosensitizes breast carcinoma cells.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Bcl-2 antisense oligodeoxynucleotide chemosensitizes breast carcinoma cells. According to recent research published in the journal Breast, "this study was designed to observe whether the rates of...

Indole-3-carbinol augments IFN responsiveness in breast tumor cells.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Indole-3-carbinol (I3C) augments IFNgammaR1 gene expression and interferon responsiveness in breast tumor cells. I3C, "a naturally occurring compound of Brassica vegetables, has promising...

LMWH as thromboembolic prophylaxis associated with postoperative hematoma.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Researchers from Denmark found that following breast cancer surgery, low-molecular-weight heparin (LMWH) as thromboembolic prophylaxis was significantly associated with postoperative hematoma or...

Link between dairy products and risk of breast cancer is weak.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- The association between the consumption of dairy products and risk of breast cancer is weak. "Differences in eating patterns and breast cancer rates across countries suggest that several dietary...

Farnesyl transferase inhibitors show promise as therapies for breast cancer.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Farnesyl transferase inhibitors show promise as targeted therapies for breast cancer. According to recent research published in the journal Endocrine-Related Cancer, "The ras family of...

Peptides inducing immune responses in breast cancer patients identified.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Scientists have identified HER2/neu-derived peptides capable of inducing both cellular and humoral immune responses in HLA-A24 positive breast cancer patients. "HRE2/neu-specific cellular and...

Tamoxifen and soluble tumor-associated antigens suppress breast cancer.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Treatment with tamoxifen and soluble tumor-associated antigens stimulate T- and B-lymphocyte responses to breast cancer tumors. According to recent research published in the journal Oncology...

Vaccine protects mice against virulent Brucella melitensis.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M. "Human brucellosis can be acquired from infected animal tissues by...

$1.2M NIH grant awarded for continued research on bead-based proteomic arrays.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Illumina, Inc., (ILMN) has been awarded a $1.2 million phase II SBIR grant from the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health (NIH), for...

Biopharmaceutical outsourcing organization reports financial results.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- PAREXEL International Corporation (NASDAQ:PRXL) announced its financial results for the fourth quarter and fiscal year ended June 30, 2004. For the 3 months ended June 30, 2004, PAREXEL's...

Bioscience company reports financial results, provides business update.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- QIAGEN N.V. (Nasdaq: QGENF; Frankfurt, Prime Standard: QIA) announced the results of operations for its second quarter and 6-month period ended June 30, 2004. The company reported that net sales...

Company reports $8.8M Q2 loss, provides clinical update.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Emisphere Technologies, Inc., (EMIS) announced results for the second quarter ended June 30, 2004. The company also highlighted its progress in development programs using its proprietary eligen...

Company reports strong Cialis sales, updates second quarter.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- ICOS Corp. (ICOS) released its financial results for the 3 and 6 months ended June 30, 2004, and summarized recent events. During the 2004 second quarter, worldwide sales of Cialis, a treatment for...

Life sciences company reports on second quarter 2004 results.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- ProMetic Life Sciences Inc. (TSX: PLI) reported on its business and financial results for the second quarter ended June 30, 2004. - Human cytotoxic T lymphocites (CTL) stimulated by PBI-1393 proven...

LymphoStat-B maker reports losses, milestones in Q2 2004.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc., (HGSI) announced financial results for the 3-month and 6-month periods ended June 30, 2004. The company's actual net loss for the quarter ended June 30, 2004, in...

Pharma company reports second quarter 2004 results.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Point Therapeutics, Inc., (NASDAQ: POTP) reported results for the fiscal quarter and 6 months ended June 30, 2004. During the second quarter of 2004, Point achieved the following key milestones:...

Pharmaceutical firm reports on IPO, financial results.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Alnylam Pharmaceuticals, Inc., (ALNY) reported its consolidated financial results for the quarter ended June 30, 2004. Alnylam is focused on creating a significant and sustainable product pipeline...

Radiation therapy provider reports second quarter 2004 financial results.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Radiation Therapy Services, Inc., (NASDAQ:RTSX) announced its financial results for the second quarter and 6 months ended June 30, 2004. On June 18, 2004, Radiation Therapy began trading as a public...

Biological products manufacturer extends distribution alliance with Hitachi.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- SeraCare Life Sciences, Inc., (SRLS), in conjunction with its Genomics Collaborative (GCI) division, has extended its strategic distribution alliance with Hitachi High-Technologies Corporation (Hitachi)...

Biopharmaceutical company and ARC Ventures form Phytomedicinal Greenhouses.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Phytomedics Inc. and ARC Ventures Inc. announced that they have entered a joint venture called Phytomedicinal Greenhouses LLC (PMG). The primary function of PMG will be the development of an...

Bioscience company retains McDermott Will & Emery.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- PURE Bioscience (OTCBB:PURE) announced that it has retained the law firm of McDermott Will & Emery to fortify the intellectual property protection of its silver dihydrogen citrate technology. Firm...

Biotech firm creates BioSystems division.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- CeMines, Inc., a privately held company founded in 2000 that uses genomics and proteomics information as building blocks for the development of early stage diagnostics of diseases and therapeutics...

Chemoproteomics-based drug firm secures $8 million in extension of Series B financing.
September 3, 2004... 2004 SEP 3 - (NewsRx.com & NewsRx.net) -- Serenex, Inc., a drug discovery company employing proprietary chemoproteomics technologies, has raised $8 million with new and existing investors in a Series B1 as an extension of its Series B private...